MedPath

Effect of Exercise and Surgical Weight Loss on Polyneuropathy

Not Applicable
Completed
Conditions
Polyneuropathies
Obesity
Bariatric Surgery Candidate
Interventions
Other: High Intensity Interval Training (HIIT)
Other: Routine Exercise
Procedure: Bariatric surgery
Registration Number
NCT03617185
Lead Sponsor
University of Michigan
Brief Summary

The purpose of this research study is to evaluate how exercise and surgical weight loss affect how likely an individual is to develop peripheral neuropathy and other neurologic complications.

Detailed Description

The length of this study, including screening is approximately 24 months. Patients at Bariatric Surgery Clinics will be recruited for this study. Both patients that decide to undergo bariatric surgery, and those that do not undergo surgery will be enrolled. Patients will be randomized to either a high intensity interval training (HIIT) or standard exercise regimen after eligibility is confirmed and the baseline visit is complete. All patients will complete follow-up appointments at 3 month, 12 months and 24 months. Patients that are randomized to the HIIT program will compete 2 supervised and 1 unsupervised training sessions a week for 24 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
140
Inclusion Criteria
  • Attending a bariatric surgery clinic
  • BMI > 35 with one comorbid condition present or BMI > 40 without comorbid conditions present
  • Willing and capable to sign the Institutional Review Board (IRB) approved consent form and cooperate with the medical procedures for the study duration
  • Willing to accept random treatment assignment to HIIT or routine exercise counseling
Read More
Exclusion Criteria
  • History of distal symmetric polyneuropathy (DSP) from causes other than diabetes and/or the metabolic syndrome as determined through medical history, family history, history of medications, occupational history, history of exposure to toxins, physical and neurological examinations;
  • Use of warfarin, heparin, or other anticoagulants, which would increase the risk of complications from skin biopsy
  • Contraindication to HIIT participation including a failed exercise stress test
  • Participation in an experimental medication trial within 3 months of starting the study
  • Undergoing therapy for malignant disease other than basal-cell or squamous-cell skin cancer
  • Medical or psychiatric reason for not being a surgical candidate
  • Requiring a walking assist device;
  • Currently smoking
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Bariatric Surgery/HIITBariatric surgeryPatients who have undergone bariatric surgery will be randomized to this arm and will follow a high intensity interval training (HIIT) protocol for 24 months. Patients will complete 2 supervised HIIT sessions and 1 unsupervised HIIT session a week.
Bariatric Surgery/HIITHigh Intensity Interval Training (HIIT)Patients who have undergone bariatric surgery will be randomized to this arm and will follow a high intensity interval training (HIIT) protocol for 24 months. Patients will complete 2 supervised HIIT sessions and 1 unsupervised HIIT session a week.
Bariatric Surgery/Routine ExerciseRoutine ExercisePatients who have undergone bariatric surgery will be randomized to this arm and will follow a standard routine exercise regimen for 24 months.
No Bariatric Surgery/HIITHigh Intensity Interval Training (HIIT)Patients who have not undergone bariatric surgery will be randomized to this arm and will follow a high intensity interval training (HIIT) protocol for 24 months. Patients will complete 2 supervised HIIT sessions and 1 unsupervised HIIT session a week.
Bariatric Surgery/Routine ExerciseBariatric surgeryPatients who have undergone bariatric surgery will be randomized to this arm and will follow a standard routine exercise regimen for 24 months.
No Bariatric Surgery/Routine ExerciseRoutine ExercisePatients who have not undergone bariatric surgery will be randomized to this arm and will follow a standard routine exercise regimen for 24 months.
Primary Outcome Measures
NameTimeMethod
Change in Intraepidermal Nerve Fiber Density (IENFD) at the proximal thighBaseline, 3 months, 12 months and 24 months

As assessed by 3mm skin biopsies.Linear mixed effects regression modeling will account for multiple time points of the same measure.

Secondary Outcome Measures
NameTimeMethod
24-2 Frequency Doubling Technology (FDT)Baseline, 3 month, 12 months and 24 months
Retinal Fundus PhotographyBaseline, 3 month, 12 months and 24 months
Nerve Conduction Study (NCS)Baseline and 24 months

Sural, peroneal, and tibial nerves.

Utah Early Neuropathy ScoreBaseline, 3 month, 12 months and 24 months

Scale 0-48, higher is more severe polyneuropathy

Survey of Autonomic Symptoms (SAS)Baseline, 3 month, 12 months and 24 months
Corneal Confocal Microscopy (CCM)Baseline, 3 month, 12 months and 24 months
Michigan Neuropathy Screening Instrument (MNSI)Baseline, 3 month, 12 months and 24 months
Short Form McGill Pain QuestionnaireBaseline, 3 months, 12 months, 24 months
8 Foot Get Up and Go TestBaseline, 3 months, 12 months, and 24 months
Change in Intraepidermal Nerve Fiber Density (IENFD) at distal leg.Baseline, 3 months, 12 months and 24 months

As assessed by 3mm skin biopsies. Linear mixed effects regression modeling will account for multiple time points of the same measure.

Cardiac Autonomic Neuropathy TestingBaseline and 24 months

Valsalva- Valsalva ratio

Neuropathy Quality of Life (NeuroQOL)Baseline, 3 months, 12 months, and 24 months
Modified Falls Efficacy ScaleBaseline, 3 months, 12 months, and 24 months

Range 0-140, higher score indicates less likely to fall

NIH Toolbox Cognitive BatteryBaseline and at 24 months
Incidence of polyneuropathy as defined by the Toronto definition of probable neuropathy24 months

Toronto definition of probable neuropathy-2 out of 3 of abnormal sensory examination, reflexes, and symptoms.

Modified Toronto Neuropathy Score (mTNS)Baseline, 3 month, 12 months and 24 months

Range 0-33, higher is more severe polyneuropathy

Numerical Rating Scale for painBaseline, 3 months, 12 months, 24 months

Range 0-10, higher score indicates more pain

NeurothesiometerBaseline, 3 months, 12 months, and 24 months
Rey Auditory Verbal Learning TestBaseline and at 24 months
Diabetic Neuropathy Score (DNS)Baseline, 3 month, 12 months and 24 months

Range 0-4, \>/=1 indicates polyneuropathy

Berg Balance ScaleBaseline, 3 months, 12 months, and 24 months

Range 0-56, higher score indicates less likely to fall

Trial Locations

Locations (1)

University Of Michigan

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath